Renaissance Capital logo

biti News

US IPO Weekly Recap: Wingstop unstoppable while massive biotech pops 99% then drops

WING

Five IPOs raised $565 million this past week. The deals average +30% from the offer price, while none broke issue and most priced above the midpoint of the range.  78 companies have gone public in the US this year,...read more

Biotie Therapies prices IPO at $14.888

Biotie Therapies, which is developing a therapy to extend the efficacy of levodopa for Parkinson's disease, raised $56 million by offering 3.8 million ADSs at $14.888. Biotie Therapies plans to list on the NASDAQ under the symbol BITI. Biotie Therapies initially filed confidentially on 3/17/2015. RBC Capital Markets and Stifel acted as lead managers on the deal....read more

Under-the-tongue Parkinson's therapy: Cynapsus Therapeutics sets terms for $64 million US IPO

Cynapsus Therapeutics, which is developing a sublingual formulation of an approved therapy for Parkinson's disease, announced terms for its IPO on Tuesday. Cynapsus is currently listed on the Toronto Stock Exchange under the symbol CTH with a basic market cap of about $100 million. The Toronto, Canada-based company plans to offer 4.5 million shares, which would generate...read more

Week ahead: 6 IPOs planned for the week of June 8

WING

Fast casual chicken wing chain Wingstop leads the six deals on this week's IPO calendar. After three weeks without a biotech, we'll see one with a proposed valuation of $1.4 billion. The four other IPOs each have a market cap under $250 million, and include a regional bank, biotech, medical device company...read more